University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Ketamine and fMRI for Neuropathic Pain

Not Applicable

Completed

Conditions: Neuralgia

Interventions: Other: RS-fMRI
Drug: Ketamine

First Posted Date: 2015-02-27

Last Posted Date: 2021-04-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 39

Registration Number: NCT02373449

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Geographic Atrophy and Intravitreal Ranibizumab Injections

Conditions: Age-related Macular Degeneration
Geographic Atrophy

Interventions: Drug: Ranibizumab

First Posted Date: 2015-02-26

Last Posted Date: 2015-02-26

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 90

Registration Number: NCT02372916

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients

Not Applicable

Completed

Conditions: Cytomegalovirus Viraemia

Interventions: Drug: Valganciclovir or Ganciclovir

First Posted Date: 2015-02-25

Last Posted Date: 2017-09-21

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 32

Registration Number: NCT02370758

Locations: 🇨🇦
University Health Network, Toronto General Hospital, Multi-Organ Transplant, Toronto, Ontario, Canada

Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes

Not Applicable

Terminated

Conditions: Type 2 Diabetes Mellitus

Interventions: Behavioral: Mobile application for diabetes self-management

First Posted Date: 2015-02-25

Last Posted Date: 2021-09-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 23

Registration Number: NCT02370719

Locations: 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada

12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

Phase 2

Completed

Conditions: Bipolar Depression

Interventions: Other: Saline
Drug: Infliximab

First Posted Date: 2015-02-16

Last Posted Date: 2021-07-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT02363738

Locations: 🇺🇸
VA Palo Alto Health Care System, Palo Alto, California, United States
🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Optic Nerve Sheath Diameter in Patients With Intracranial Pathology

Completed

Conditions: Elevated Intracranial Pressure (ICP)

First Posted Date: 2015-02-12

Last Posted Date: 2023-08-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT02361671

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

CALM Phase 2b Pilot

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: CALM

First Posted Date: 2015-02-02

Last Posted Date: 2023-08-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT02353546

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia

Not Applicable

Completed

Conditions: Acute Leukemia

Interventions: Behavioral: EASE

First Posted Date: 2015-02-02

Last Posted Date: 2019-09-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 47

Registration Number: NCT02353559

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Decompression vs. Fusion for Stable Degenerative Spondylolisthesis

Not Applicable

Active, not recruiting

Conditions: Spinal Stenosis
Spondylolisthesis

Interventions: Procedure: Spinal fusion
Procedure: Spinal decompression

First Posted Date: 2015-01-28

Last Posted Date: 2022-11-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 70

Registration Number: NCT02348645

Locations: 🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

and more 5 locations

The Effect of Uric Acid Lowering in Type 1 Diabetes

Phase 4

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: Febuxostat

First Posted Date: 2015-01-26

Last Posted Date: 2018-01-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 73

Registration Number: NCT02344602

Locations: 🇨🇦
Renal Physiology Laboratory, University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy